Joined October 2009
Such an amazing time catching up with everyone @Neurodiab_eu. Takk så mye @Diabeteslegen for being a fantastic host!
Congratulations to Dr @ShazliAzmi for being awarded the Göran Sundkvist Young Investigators #Award for Clinical Science @Neurodiab_eu for her impressive & intense #research career on the utility of #corneal confocal #microscopy in diabetic neuropathy under @Rayazamalik mentorship
5
30
Shazli Azmi retweeted
A big thank you to everyone who joined the #NEUROdiab Symposium at #EASD2026 in Milan. Excellent science, lively discussion, and great participation onsite and online. 🎥 Replay available here: virtualcongress.easd.org/pag…
8
13
397
Replying to @Neurodiab_eu
@Neurodiab_eu @EASDnews #EASD2026 Congratulations to Dr Uzmaan Alarm to be one of the Future leaders award winners. Inspiring work in the field of AI and DPN (AIDEN Study) – at Milan, Lombardy
5
10
171
Shazli Azmi retweeted
Great first session of the pre-congress workshop in Athens at #NeuroDiab2026 - finishing off with a spectacular lecture from my mentor @solomon19400 with some amazing views at dinner!
3
12
216
Replying to @Neurodiab_eu
@Neurodiab_eu Youth Committee in Athens 🇬🇷 Another great meeting and our second annual debate done! @GordonSloan9 @lucadonofrio88 @ShazliAzmi
6
26
739
Delighted to be presenting at the @Neurodiab_eu pre-congress workshop 🇬🇷 It’s a great opportunity for early-career researchers. Applications are still open!
Only seven days to apply for the Early Career Pre-Congress Workshop 2026, at Athens Meeting of NEUROdiab, a collaboration between the Youth Committee and Viatris to support the next generation of #diabeticneuropathy researchers. Apply here docs.google.com/forms/d/e/1F…
4
14
1,226
Shazli Azmi retweeted
The Advanced program of the 36th Annual Meeting of NEUROdiab - Diabetic Neuropathy Study Group is now available at: neurodiabgreece.gr/#/Program neurodiab.eu/annual-meeting-… Register at neurodiabgreece.gr/#/Registr…
3
1
6
2,036
Shazli Azmi retweeted
Thrilled to invite for the Early Career Pre-Congress Workshop 2026, at Athens Meeting of NEUROdiab, a collaboration between the Youth Committee and Viatris to support the next generation of #diabeticneuropathy researchers. Subscribe to NEUROdiab Newsletter neurodiab.eu/
6
7
386
Shazli Azmi retweeted
Proud moment for the NEUROdiab Youth Committee! Our first paper, born from last year’s NEUROdiab debate on whether clinical diabetic neuropathy is reversible, is now published in the journal of @PNSociety1 Special thanks to @CallaghanNeuro and Bruce Perkins for leading the debate
1
8
2
13
3,616
Shazli Azmi retweeted
Super proud of this paper - thanks to all for contributing - especially @CallaghanNeuro and Bruce Perkins
1
2
126
Join me for this year's Trans Pennine PCI meeting in Sheffield. We have a fantastic programme and faculty lined up and look forward to welcoming you. Register here: millbrook-events.co.uk/event… @MillbrookMed @sanjaysastry @ammozid and Javaid Iqbal @BCIS_uk @BCSWIC
1
2
5
321
Another great addition to the @Neurodiab_eu Youth Committee Hallmark Papers series, featuring the influential @cochranecollab by @CallaghanNeuro @EvaFeldmanMDPhD et al. on glucose control and diabetic neuropathy Plus an author perspective from Brian himself. Worth checking out 👇🏻
The NEUROdiab Youth Committee continues its initiative of Hallmark Papers highlighting seminal articles in #diabeticneuropathy. The 3rd paper is the Cochrane review on glucose control and diabetic neuropathy with a comment of Prof. Brian Callaghan (neurodiab.eu/education-tools)
3
10
855
Shazli Azmi retweeted
Feeding and moving the nerve: a metabolic cure for neuropathy? On Neurodiab website a signaling of articles on #diabeticneuropathy The 224th Publication News is by Shazli Azmi (neurodiab.eu/publication-new…)
4
1
7
816
🇩🇰🇪🇸 Grand Finale 19th #ATTD2026. 5 Great Days of #DiabetesTechnology, 5300 delegates, 105 nations, 945 abstracts, +200 lectures, 21 industry symposia. #StenoNord proudly delivered 4 PROMS-VBHCi presentations 😊Thank you ever so much for great learnings & friendships, everybody😊
1
3
9
484
Shazli Azmi retweeted
The BOND study: no effect on neuropathy of one year of benfotiamine in people with type 2 diabetes and symptomatic polyneuropathy On Neurodiab website a signaling of articles on #diabeticneuropathy The 217th Publication News is by Maryam Ferdousi (neurodiab.eu/publication-new…)
1
5
7
739
Shazli Azmi retweeted
Don’t miss tomorrow’s NEUROdiab Youth Committee Webinar on diabetic peripheral neuropathy & metabolic disorders! 🧠 Join us at 7:00 pm (GMT) and be part of the discussion ! @CallaghanNeuro @ShazliAzmi @VinceSpallone @Neurodiab_eu
Only 1 day until the 3rd NEUROdiab Youth Committee Webinar on #diabeticneuropathy and metabolic disorder 3 March 2026 at 7:00 pm (GMT) Don’t miss this opportunity and get the free ticket here: buytickets.at/orangejuicecom… [buytickets.at]
6
8
572
Shazli Azmi retweeted
The 3rd free Webinar of NEUROdiab Youth Committee is on 3 March 2026 at 7:00pm (BST) (buytickets.at/orangejuicecom… [buytickets.at]) Don’t miss the opportunity to hear from leading experts in #diabeticneuropathy how metabolic and lipid-related risk factors play a role
7
1
10
1,824
Shazli Azmi retweeted
On the 2026 International Day of Women and Girls in Science, NEUROdiab recognises the contributions of young women scientists to research and treatment of #diabeticneuropathy
4
6
187
Shazli Azmi retweeted
Diabetic neuropathies in Greenland: the role of Inuit ancestry and modernization in disease prevalence On Neurodiab website a signaling of articles on #diabeticneuropathy The 202nd Publication News is by Johan Røikjer (neurodiab.eu/publication-new…)
1
6
12
944
Shazli Azmi retweeted
Insights into inflammation and axonal loss in human diabetic neuropathy: a real step forward On Neurodiab website a signaling of articles on #diabeticneuropathy The 203rd Publication News is by Stephanie Eid (neurodiab.eu/publication-new…)
5
1
14
926
Shazli Azmi retweeted
#WorldDiabetesDay2025 is focused on "Diabetes at work" The NEUROdiab Youth Committee is committed to addressing #diabeticneuropathy and pain to limit their impact on the well-being and improve the daily lives and work experience of people with diabetes.
5
1
9
828